01
Eligibility
Structured criteria define who benefits and when.
Precision Medicine
Precision medicine needs more than better science.
It needs the operational layer science alone cannot provide: clinical pathways, interpretation, behaviour change, follow-up, governance, delivery, technology, evidence and continuous improvement. Every one of those is a design problem — and it is where most innovations fail.
Framework · Nº 01 / 05
GMG–GKIM signatureThe Precision Medicine Adoption Gap™
Between validated science and routine clinical care sits an operational layer — eligibility, interpretation, workflow, follow-up, evidence. Invisible in a trial. Decisive in practice. This is the gap most precision innovations never cross.
Longitudinal care
Care that continues after the result.
A genomic or molecular result is a beginning, not an endpoint. Longitudinal care means eligibility, interpretation, personalised follow-up, escalation pathways and continuous outcome measurement — coordinated across the patient's journey. Most healthcare systems are still organised around the encounter, not the pathway.
02
Interpretation
Clinical review situates results in the patient's context.
03
Follow-up
Care plans and reassessment on defined cadences.
04
Outcomes
Continuous measurement feeds programme improvement.
Governance
Governance is not a compliance layer. It is the product.
Clinical governance is usually described as something bolted onto care. In a Medical Programme it is the other way round: governance is the design decision that determines what the programme is allowed to do, who is accountable for each decision, and how outcomes feed back into protocol. Everything else is packaging.
The methodology that makes this operational is Healthcare Productisation™ — the signature framework introduced on the Medical Programmes page.
Next